Alexza Pharmaceuticals, Inc.
26 clinical trials · Sponsor
◉ Watch Alexza Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| Study to Evaluate the Efficacy and Safety of Staccato Apomorphine (AZ-009) in Patients With Parkinson's Disease Experiencing OFF Episodes (NCT05979415) | Alexza Pharmaceuticals, Inc. | 2023-09-27 |
| Staccato Granisetron® (AZ 010) for the Treatment of Cyclic Vomiting Syndrome (NCT04645953) | Alexza Pharmaceuticals, Inc. | 2021-02-05 |
| Staccato® Granisetron Multiple Dose PK (NCT04327765) | Alexza Pharmaceuticals, Inc. | 2020-03-10 |
| Staccato Apomorphine Multi-dose PK and PD in Patients With Parkinson's Disease (NCT04157933) | Alexza Pharmaceuticals, Inc. | 2019-10-16 |
| Staccato Apomorphine Single and Multi Dose PK (NCT03822364) | Alexza Pharmaceuticals, Inc. | 2018-11-26 |
Track Alexza Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.